Andrew Lu

444 total citations
9 papers, 377 citations indexed

About

Andrew Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andrew Lu has authored 9 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Andrew Lu's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Andrew Lu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Andrew Lu collaborates with scholars based in United States, China and Germany. Andrew Lu's co-authors include Yi Lü, Liyuan Li, Jianhong Luo, Yana K. Reshetnyak, Wise Young, Dongming Sun, Tianyi Li, Oleg A. Andreev, Xin Sun and Yi Ren and has published in prestigious journals such as Nature Medicine, PLoS ONE and Cancer Research.

In The Last Decade

Andrew Lu

9 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Lu United States	8	205	81	76	68	58	9	377
Bing Lu-jun China	8	231 1.1×	48 0.6×	77 1.0×	90 1.3×	49 0.8×	11	420
Mario Mauri Italy	12	356 1.7×	85 1.0×	90 1.2×	69 1.0×	29 0.5×	30	587
Sarah Teuber‐Hanselmann Germany	13	119 0.6×	53 0.7×	52 0.7×	64 0.9×	55 0.9×	22	412
Sang Mi Shim South Korea	13	404 2.0×	59 0.7×	50 0.7×	76 1.1×	28 0.5×	13	661
Zhijie Wang China	14	186 0.9×	91 1.1×	128 1.7×	39 0.6×	63 1.1×	28	407
Mariane da Cunha Jaeger Brazil	12	239 1.2×	105 1.3×	44 0.6×	28 0.4×	62 1.1×	34	429
Scott Foster United States	11	158 0.8×	48 0.6×	43 0.6×	42 0.6×	69 1.2×	11	440
Shuwen Shen China	10	272 1.3×	78 1.0×	168 2.2×	55 0.8×	28 0.5×	27	518
Koppany Visnyei United States	9	221 1.1×	88 1.1×	113 1.5×	164 2.4×	33 0.6×	12	497

Countries citing papers authored by Andrew Lu

Since Specialization

Citations

This map shows the geographic impact of Andrew Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lu more than expected).

Fields of papers citing papers by Andrew Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lu. The network helps show where Andrew Lu may publish in the future.

Co-authorship network of co-authors of Andrew Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Lu. A scholar is included among the top collaborators of Andrew Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Lu. Andrew Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

He, Xuelian, Liguo Zhang, Luis F. Queme, et al.. (2018). A histone deacetylase 3–dependent pathway delimits peripheral myelin growth and functional regeneration. Nature Medicine. 24(3). 338–351. 81 indexed citations

2.

Yu, Yanlin, et al.. (2018). PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation. Oncogene. 37(17). 2225–2236. 25 indexed citations

3.

Rohira, Aarti D., Fei Yan, Lei Wang, et al.. (2017). Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells. Cancer Research. 77(16). 4293–4304. 37 indexed citations

4.

Lü, Yi, et al.. (2014). Development of a Novel Anti-HIF-1α Screening System Coupled with Biochemical and Biological Validation for Rapidly Selecting Potent Anti-Cancer Compounds. Journal of Cancer. 5(6). 417–424. 5 indexed citations

5.

Wijesinghe, Dayanjali, et al.. (2013). pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis. Scientific Reports. 3(1). 3560–3560. 44 indexed citations

6.

Sun, Xin, Xi Wang, Tianxiang Chen, et al.. (2010). Myelin Activates FAK/Akt/NF-κB Pathways and Provokes CR3-Dependent Inflammatory Response in Murine System. PLoS ONE. 5(2). e9380–e9380. 105 indexed citations

7.

Zhang, Jun, Andrew Lu, Liyuan Li, Junming Yue, & Yi Lü. (2010). p16 Modulates VEGF Expression via Its Interaction With HIF-1α in Breast Cancer Cells. Cancer Investigation. 28(6). 588–597. 29 indexed citations

8.

Li, Liyuan, Chikezie O. Madu, Andrew Lu, & Yi Lü. (2010). HIF-1α Promotes A Hypoxia-Independent Cell Migration. PubMed. 3(1). 8–14. 19 indexed citations

9.

Zhang, Jun, Andrew Lu, Derrick J. Beech, Bing‐Hua Jiang, & Yi Lü. (2007). Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis.. PubMed. 5. 273–286. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact